2024 ASCO Gastrointestinal Cancers Symposium ASCO GI 2024: Radioligand Therapy for Gastroenteropancreatic Neuroendocrine Tumors
2024 ASCO Gastrointestinal Cancers Symposium ASCO GI 2024: ctDNA as a Predictive Biomarker for Patients With Colon Cancer
Leukemia Real-World Genomic Testing and Treatment Patterns for Adult Patients Newly Diagnosed With Leukemia
Graft-vs.-Host Disease Blood Urea Nitrogen-to-Albumin Ratio Predicts Mortality in Acute Graft-Versus-Host Disease After Allogeneic Stem Cell Transplantation